Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention
- PMID: 23451765
- PMCID: PMC3663901
- DOI: 10.1111/jcpp.12061
Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention
Abstract
Background and scope: The social motivation hypothesis (SMH) suggests that individuals with autism spectrum disorders (ASD) are less intrinsically rewarded by social stimuli than their neurotypical peers. This difference in social motivation has been posited as a factor contributing to social deficits in ASD. Social motivation is thought to involve the neuropeptide oxytocin. Here, we review the evidence for oxytocin effects in ASD, and discuss its potential role in one important social cognitive behavior.
Methods: Systematic searches were conducted using the PsychINFO and MEDLINE databases and the search terms 'oxytocin' and 'autism'; the same databases were used for separate searches for 'joint attention', 'intervention', and 'autism', using the same inclusion criteria as an earlier 2011 review but updating it for the period 2010 to October 2012.
Findings: Several studies suggest that giving oxytocin to both individuals with ASD and neurotypical individuals can enhance performance on social cognitive tasks. Studies that have attempted to intervene in joint attention in ASD suggest that social motivation may be a particular obstacle to lasting effects.
Conclusions: The review of the evidence for the SMH suggests a potential role for oxytocin in social motivation deficits in ASD. Because of its importance for later communicative and social development, the focus here is on implications of oxytocin and social motivation in the development of and interventions in joint attention. Joint attention is a central impairment in ASD, and as a result is the focus of several behavioral interventions. In describing this previous research on joint attention interventions in ASD, we pay particular attention to problems encountered in such studies, and propose ways that oxytocin may facilitate behavioral intervention in this area. For future research, integrating behavioral and pharmacological interventions (oxytocin administration) would be a worthwhile experimental direction to improve understanding of the role of oxytocin in ASD and help optimize outcomes for children with ASD.
© 2013 The Authors. Journal of Child Psychology and Psychiatry © 2013 Association for Child and Adolescent Mental Health.
Conflict of interest statement
The authors have declared that they have no competing or potential conflicts of interest arising from the publication of this review.
Similar articles
-
The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.J Neurodev Disord. 2018 Mar 27;10(1):12. doi: 10.1186/s11689-018-9228-y. J Neurodev Disord. 2018. PMID: 29587625 Free PMC article.
-
Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12258-63. doi: 10.1073/pnas.1402236111. Epub 2014 Aug 4. Proc Natl Acad Sci U S A. 2014. PMID: 25092315 Free PMC article.
-
Parent-mediated early intervention for young children with autism spectrum disorders (ASD).Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009774. doi: 10.1002/14651858.CD009774.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633377 Review.
-
Atypical neural networks for social orienting in autism spectrum disorders.Neuroimage. 2011 May 1;56(1):354-62. doi: 10.1016/j.neuroimage.2011.02.031. Epub 2011 Feb 18. Neuroimage. 2011. PMID: 21334443 Free PMC article.
-
Neural targets in the study and treatment of social cognition in autism spectrum disorder.Handb Exp Pharmacol. 2015;228:309-34. doi: 10.1007/978-3-319-16522-6_11. Handb Exp Pharmacol. 2015. PMID: 25977088 Review.
Cited by
-
The Construct Validity of the Childhood Joint Attention Rating Scale (C-JARS) in School-Aged Autistic Children.J Autism Dev Disord. 2023 Jul 22. doi: 10.1007/s10803-023-06051-1. Online ahead of print. J Autism Dev Disord. 2023. PMID: 37480436
-
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.Schizophr Bull. 2023 Sep 7;49(5):1161-1173. doi: 10.1093/schbul/sbad094. Schizophr Bull. 2023. PMID: 37358825 Free PMC article. Review.
-
Vasopressin, and not oxytocin, receptor gene methylation is associated with individual differences in receptive joint attention in chimpanzees (Pan troglodytes).Autism Res. 2023 Apr;16(4):713-722. doi: 10.1002/aur.2895. Epub 2023 Feb 4. Autism Res. 2023. PMID: 36738470 Free PMC article.
-
The Bidirectional Social-Cognitive Mechanisms of the Social-Attention Symptoms of Autism.Front Psychiatry. 2022 Jan 31;12:752274. doi: 10.3389/fpsyt.2021.752274. eCollection 2021. Front Psychiatry. 2022. PMID: 35173636 Free PMC article.
-
From Gaze Perception to Social Cognition: The Shared-Attention System.Perspect Psychol Sci. 2021 May;16(3):553-576. doi: 10.1177/1745691620953773. Epub 2021 Feb 10. Perspect Psychol Sci. 2021. PMID: 33567223 Free PMC article. Review.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: Author; 1994.
-
- Bacon AL, Fein D, Morris R, Waterhouse L. The responses of autistic children to the distress of others. Journal of Autism and Developmental Disorders. 1998;28:129–142. - PubMed
-
- Bakeman R, Adamson LB. Coordinating attention to people and objects in mother-infant and peer-infant interaction. Child Development. 1984;55:1278–1289. - PubMed
-
- Bales KL, Perkeybile AM. Developmental experiences and the oxytocin receptor system. Hormones and Behavior. 2012;61:313–319. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical